Growth and Cost Savings Contributed Significantly to Fourth Quarter Profitability and Cash Flow Building on Year-End Momentum, Company Provides Robust Fiscal 2025 Outlook ...
Analysts have been eager to weigh in on the Consumer Goods sector with new ratings on Hormel Foods (HRL – Research Report) and SpartanNash Co ...
Inventiva’s lanifibranor has been tipped to become a blockbuster in the fatty liver disease non-alcoholic steatohepatitis (NASH) after it became the first drug to hit two regulatory goals in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback